Mechanisms of GLP-1, Dual, and Triple Agonists in Adolescent Obesity The development of glucagon-like peptide-1 receptor agonists (GLP-1RAs), followed by the emergence of dual and triple incretin-based therapies, has substantially expanded pharmacological options for the management of obesity
The researchers found that people who used tirzepatide had greater weight loss (20.2% of body weight) than those who used semaglutide (13.7% of body weight)
Visser, M., van der Stoep, N
If you have kidney disease or are on blood pressure medicines, check with your clinician about the correct fluid and electrolyte plan
33 (Suppl 1): S11S15
Since our data suggest that the urea cycle in AKI is already overloaded, it is uncertain what levels of protein intake are necessary to meet metabolic needs and at what point a high protein intake will overwhelm the urea cycle and ammoniagenesis